ResMed Inc.
NYSE-RMD
Company Overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Name
ResMed Inc.
CEO
Mr. Michael J. Farrell BE, MBA, SM
Website
www.resmed.com
Sector
Health Care Equipment and Supplies
Year Founded
1989
Profile
Market Cap
$34.97B
EV
$35.61B
Shares Out
146.93M
Revenue
$4,685.3M
Employees
9,980
Margins
Gross
57.38%
EBITDA
32.73%
Operating
29.54%
Pre-Tax
27%
Net
21.79%
FCF
27.78%
Returns (5Yr Avg)
ROA
13.6%
ROTA
27.08%
ROE
22.87%
ROCE
22.34%
ROIC
16.97%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$208.56
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$238.36M
Net Debt
$635.57M
Debt/Equity
0.18
EBIT/Interest
27.84
Growth (CAGR)
Rev 3Yr
13.59%
Rev 5Yr
12.44%
Rev 10Yr
11.66%
Dil EPS 3Yr
28.78%
Dil EPS 5Yr
19.84%
Dil EPS 10Yr
11.22%
Rev Fwd 2Yr
7.33%
EBITDA Fwd 2Yr
10.87%
EPS Fwd 2Yr
13.58%
EPS LT Growth Est
13.39%
Dividends
Yield
—
Payout
27.65%
DPS
$1.92
DPS Growth 3Yr
6.49%
DPS Growth 5Yr
5.06%
DPS Growth 10Yr
6.74%
DPS Growth Fwd 2Yr
9.72%